Skip to content

BD Infection Prevention

Active Private limited companyfounded 2019active for 7 yearsErembodegem-Dorp 86, 9320 AalstKBO/BCE: BE 0726.931.262

Lifetime

7 annual accounts with figures on one time axis
peak of €24.7m in 2024
€17.1m▼ 30.8%
peak of €161,082 in 2024
€156,359▼ 2.9%
peak of €871,765 in 2025
€871,765▲ 21.9%
€6.8m▼ 5.4%
peak of 1.8 FTE in 2021
-not published
Board5 names since 2019
1 director
Documentsfilings and deeds
26-02-202663 days before the deadline
2025financial year; the figures come from the scanned accounts
Turnover from €24.7m to €17.1mPower of attorney granted to 19-05Power of attorney granted to 07-05 acts as permanent representative 24-03 and act as permanent representatives 03-03Equity from €715,406 to €871,765

Key points

from the 2025 annual accounts

Equity

€871,765 ▲ 21.9%

BD Infection Prevention has made a profit in every financial year since 2019.

Growth

4 years
201920202021202220232024

4 years of growth in a row. Turnover of €24.7m in 2024.

Debts

€6.8m 89% of the balance sheet
After one year 1%Within one year 99%

Of this, €6.7m falls due within a year.

Filings

7 annual accounts since 2019
deadline202020222024

The last five annual accounts were filed 19 to 63 days before the end of the period.

Board

1 left

A director left. Latest change 31-12-2025 · 0 in office.

Position in the sector

11.3%

Lower solvency than 87% of companies in wholesale trade. Sector median 43.8% · 3,788 companies.

Bankruptcy probability

No current score
Figures too old
The latest figures are for FY 2024. They are too old for a current score.
Bankruptcy probability: Elevated
Bankruptcy probability within 12 months

Financial strength, FY 2024

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

last known board
Director, until 2025
Auditor,
  • founderdeed of 22-05-2019
Board & ownership

Recent changes

resigns as director General meeting of 17-02-2026 · Gazette deed
acts as permanent representative reappointed as statutory auditor · General meeting of 04-03-2025 · Gazette deed
and act as permanent representatives General meeting of 27-01-2025 · Gazette deed
appointed as director “De vennootschap heeft tot voorwerp, zowel in België als in het buitenland, voor eigen rekening of voor…” (deed in Dutch) · General meeting of 21-12-2023 · Gazette deed
All 23 events

Comparable companies

same main activity, similar in size and age
Company
BD Infection Prevention Aalst €17.1m 1.8% 11.3% -
Magis-Pharma Antwerp €14.7m 0.7% 2.0% 55.2
Orifarm Healthcare Zaventem €31.3m 1.5% 26.1% 21.5
ELYSIA Seraing €12.8m 8.9% 51.7% 23.3
Elanco Belgium Antwerp €27.1m 2.7% 80.0% 54
PerkinElmer (Belgium) Kraainem €13.3m 3.3% 3.8% 31.6
Demant Belgium Leuven €17.3m 4.9% 12.1% 9.5
-10%0%10%20%€20m€200m€2bn€20bnBD Infection PreventionEBIT margin

Grey: the largest companies of the sector (wholesale trade (NACE 46)), without their names. Blue: the sector peers from the table.

These companies have the same main activity as BD Infection Prevention: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €6.5m and €19m, founded between 2014 and 2023.

Official details

Source: KBO
Status
Active since 20-05-2019Normal situation
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Establishment units
2.300.767.8439320 Aalst, since 20-05-2019
2.352.751.5292250 Olen, since 01-01-2024
Financial year end
30 September
Peppol
Reachable since 08-09-2022
Company details

Annual accounts to 30-09-2024

€7.9m▲ 14.8%
≈ 8.5 FTEestimated
Filing
Annual accounts to 30-09-2025 filed on 26-02-2026, 63 days before the end of the filing period
Financials

Insights on BD Infection Prevention

BD Infection Prevention has existed since 2019. Turnover grew from €7.7m in 2020 to €17.1m in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about BD Infection Prevention

What is the company number of BD Infection Prevention?
The company number of BD Infection Prevention is 0726.931.262. The VAT number is the same number with BE in front: BE 0726.931.262.
Where is BD Infection Prevention based?
The registered office is at Erembodegem-Dorp 86, 9320 Aalst.Company details
What does BD Infection Prevention do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of BD Infection Prevention?
BD Infection Prevention is a private limited company (BV).
When was BD Infection Prevention founded?
BD Infection Prevention was founded on 20-05-2019.
Is BD Infection Prevention still active?
Yes, BD Infection Prevention is an active enterprise in the KBO register.
How many employees does BD Infection Prevention have?
BD Infection Prevention had an average of 1 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
What is the turnover of BD Infection Prevention?
The turnover of BD Infection Prevention was €24.7m in financial year 2024, according to the filed annual accounts.
Is BD Infection Prevention profitable?
In financial year 2024, BD Infection Prevention made a profit of €161,082.
Where can I find the annual accounts of BD Infection Prevention?
BD Infection Prevention filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of BD Infection Prevention due?
BD Infection Prevention must file the annual accounts for financial year 2026 by 30-04-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.